Content
@
0 reply
0 recast
0 reaction
hyunii🌹🔥
@hyuni
The company plans to start assessing the effects of semaglutide, the active ingredient in Ozempic, and other medicines on alcohol consumption this month in a newly announced clinical trial in alcohol-related liver disease – although cutting drinking isn’t the study’s main goal.
6 replies
23 recasts
24 reactions
Anyugenie
@anyujin
nice news
0 reply
0 recast
0 reaction
chocomm🎩🍖
@chocomm
This research is exciting to see what the results will be 160 $degen
0 reply
0 recast
0 reaction
biinnn
@biinnn
Drinking too much alcohol is still bad :(
0 reply
0 recast
0 reaction
